GB201902454D0 - Dosage regimen - Google Patents
Dosage regimenInfo
- Publication number
- GB201902454D0 GB201902454D0 GBGB1902454.6A GB201902454A GB201902454D0 GB 201902454 D0 GB201902454 D0 GB 201902454D0 GB 201902454 A GB201902454 A GB 201902454A GB 201902454 D0 GB201902454 D0 GB 201902454D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- dosage regimen
- regimen
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1902454.6A GB201902454D0 (en) | 2019-02-22 | 2019-02-22 | Dosage regimen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1902454.6A GB201902454D0 (en) | 2019-02-22 | 2019-02-22 | Dosage regimen |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201902454D0 true GB201902454D0 (en) | 2019-04-10 |
Family
ID=65998896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1902454.6A Ceased GB201902454D0 (en) | 2019-02-22 | 2019-02-22 | Dosage regimen |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201902454D0 (en) |
-
2019
- 2019-02-22 GB GBGB1902454.6A patent/GB201902454D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2594345B (en) | Single dosage shampoo | |
GB201713653D0 (en) | Dosage regimen | |
IL275708A (en) | G1t38 superior dosage regimes | |
IL253247A0 (en) | Dosage regimen for madcam antagonists | |
IL287132A (en) | Abuse-deterrent dosage forms containing esketamine | |
GB201521217D0 (en) | Dosage regimens | |
IL281968A (en) | Dosage regimen for tfpi antagonists | |
FI4058148T3 (en) | Dosing regimen for anti-bcma agents | |
GB201910787D0 (en) | Pharmaceutical development | |
EP4055061A4 (en) | Dosage regimen for anti-egfrviii agents | |
CA195194S (en) | Can | |
EP4054636A4 (en) | Dosing regimen for anti-dll3 agents | |
IL266255A (en) | Novel dosage regimen | |
GB201901989D0 (en) | Pharmaceutical combinations | |
GB201902454D0 (en) | Dosage regimen | |
ZA201800217B (en) | Novel dosage regimen tiacumicin compound | |
GB202015771D0 (en) | Dosage regimen | |
GB202014116D0 (en) | Dosage regimen | |
GB202006819D0 (en) | Dosage regimen | |
GB202006699D0 (en) | Dosage regimen | |
CA194487S (en) | Barrier | |
GB202319534D0 (en) | Dosage regimen | |
GB201814818D0 (en) | Treatment Regimen | |
GB202306662D0 (en) | Dosage regimen | |
CA191469S (en) | Package |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |